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Abstract 
The four components present in the trypanocidal treatment Samorin, the commercially 
available formulation of isometamidium, were separated and purified by column 
chromatography. These compounds as well as the Samorin mixture and the other 
phenanthridine trypanocide, homidium, were tested on Trypanosoma congolense and 
wild type, diamidine- and isometamidium-resistant Trypanosoma brucei brucei strains 
using an Alamar blue drug sensitivity assay. EC50 values obtained suggest that 
M&B4180A (2) was the most active of the components, followed by M&B38897 (1) in 
all the strains tested, whereas M&B4596 (4) was inactive. Samorin was found to be 
significantly more active than any of the individual components alone, against T. 
congolense and all three T. b, brucei strains. Samorin and all its active constituents 
displayed reduced activity against the previously characterised isometamidium-resistant 
strain ISMR1. 
Keywords 
Isometamidium, Trypanosoma congolense, Trypanosoma brucei brucei, Samorin, drug 
resistance.   
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1. Introduction 
Trypanosoma brucei brucei, T. congolense and T. vivax are responsible for African 
animal trypanosomiasis (AAT) or nagana in cattle (Giordani et al., 2016). Control of 
these tsetse-fly transmitted animal trypanosomes in sub-Saharan Africa, in the absence 
of a vector control programme or an effective vaccine, depends solely on chemotherapy 
using isometamidium (ISM), diminazene and ethidium bromide. If ethidium bromide is 
withdrawn from use due to its established mutagenic properties (Sayas et al., 2015), 
ISM and diminazene would be the only trypanocides left for prophylaxis and treatment 
of veterinary African trypanosomiasis respectively (Delespaux and De Koning, 2007). 
Resistance to ISM in this situation would therefore threaten the control of animal 
trypanosomiasis. Resistance to ISM in the field has been confirmed by a number of 
reports (Jamal et al., 2005; Mongube et al., 2012; Moti et al., 2012; Tihon et al., 2017). 
Hence, the management of AAT requires both the introduction of new drugs and 
optimization of available drugs to increase treatment options and reduce the risk of 
resistance. Optimization of available drugs would involve the determination of their 
mechanism of action and resistance to understand how best to use the drugs and reduce 
the incidence of resistance. Resistance to ISM involves a reduction in uptake and/or loss 
of mitochondrial potential in T. congolense (Sutherland et al., 1992; Wilkes et al., 
1997), the latter of which was linked, in T. b. brucei, to mutation of the F1Fo ATPase 
complex (Eze et al., 2016).  
ISM is available commercially as the impure mixture Samorin. The four components 
which the drug is suspected to contain have been purified to homogeneity, and their 
structures have been rigorously determined by a combination of NMR and mass-
spectrometric techniques (Igoli et al., 2014). For the first time, this analysis showed that 
the Samorin components exist as reversible di-cationic chloride salts or a dihydro form, 
with a hydrogen addition to C-6 as depicted in Figure 1, depending on solvent and pH. 
The compound 8-(3-m-amidinophenyl-2-triazeno)-3-amino-5-ethyl-6-
phenylphenanthridinium chloride hydrochloride (2, M&B4180A) is believed to be the 
principal active component (Schad et al., 2008), and this is usually the structure for 
isometamidium given in the literature. The other components isolated, usually 
dismissed as impurities, were 3-(3-m-amidinophenyl-2-triazeno)-8-amino-5-ethyl-6-
phenylphenanthridinium chloride hydrochloride (1, M&B38897, ‘red isomer’), 7-(m-
amidinophenyldiazo)-3,8-diamino-5-ethyl-6-phenylphenanthridinium chloride 
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hydrochloride (3, M&B4250, ‘blue isomer’) and 3,8-di(3-m-amidinophenyltriazeno)-5-
ethyl-6-phenylphenanthridinium chloride dihydrochloride (4, M&B4596); see Figure 1. 
However, the dihydro forms were not observed using NMR with D2O instead of 
DMSO, suggesting that in aqueous solution the same compounds may be 
phenanthridinium ions without a C-6 hydrogen, consistent with the belief that this is the 
biologically active form. 
In this study, the compounds (Figure 1) obtained from the purification of Samorin were 
tested on wild type Trypanosoma brucei brucei 427 and Trypanosoma congolense 
IL3000, alongside several T. b. brucei strains, including the diamidine-resistant B48 
strain (Bridges et al., 2007) and ISM-resistant (ISMR1) strain (Eze et al., 2016). While 
a report by Sahin et al. (2014) similarly described the effect of individual compounds 
M&B4180A, M&B4250, B4596 and M&B38897 on trypanosomes, these were 
separately synthesised rather than purified from commercial Samorin, and the NMR and 
mass spectra were not made available so their identity and purity could not be verified; 
the structures were given as phenanthridinium mono-cations. Here we investigate 
whether purification of Samorin might improve activity and whether the purified 
compounds all displayed similar activity against T. b. brucei strains resistant to 
diamidines and phenanthridines, respectively. Absence of cross-resistance for some 
components would not only point to different mechanisms of action, but highlight a 
way to bypass isometamidium resistance. 
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Figure 1. Chemical structures of fractions obtained from the fractionation of Samorin. 
Compounds 1-4 were isolated by Igoli et al., 2014 and matched against their M&B 
codes. Compounds 1A and 1B are identical (compound 1) but compound 1B contains a 
significant percentage of ethidium contamination. 
 
2. Material and methods 
2.1. Drugs 
Samorin was donated by Mérial, France, while Alamar blue dye was obtained as 
Resazurin sodium salt from Sigma UK. Compounds 1- 4 were fractions from column 
chromatography purification from Samorin, provided by Professor Graham G. Skellern 
at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of 
Strathclyde, Glasgow. 
2.2. Trypanosome strains and culture 
Bloodstream-form of T. b. brucei, strain Lister 427 (s427; MiTat 1.2/BS221), and its 
derivatives, B48 (diamidine/arsenical resistant) and ISMR1 (phenanthridine resistant) 
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were maintained in full HMI-9 medium with 10% Fetal Bovine Serum at 37 ºC as 
previously described (Bridges et al., 2007). T. congolense IL3000 was grown in 
Minimum Essential Medium Eagle (MEM; Sigma; supplemented with 20% goat 
serum). Culture was grown in 5% CO2 at 34 ºC and was sub-cultured every 48 h (or 
whenever cell density reaches about 2×106 cells/ml).  
Basal MEM medium was prepared by adding the following components to a litre of 
Hipersolv Chromanorm water (BDH): 1 bottle of MEM powder (Sigma), 5.56 g of 
HEPES (Sigma), 2.2 g of NaHCO3 (Sigma), 1 g D-glucose (Fisher Scientific), 110 mg 
sodium pyruvate (Sigma), 10.68 mg adenosine (Sigma), 14 mg hypoxanthine (Sigma), 
4 mg thymidine (Sigma), 14.1 mg bathocuproine sulphate acid (Sigma). This was filter-
sterilized, after adjusting pH to 7.3, and stored at 4 ºC. 
One litre of complete Tc-BSF3 medium for T. congolense was prepared with the 
following components: 750 ml base media, 200 ml goat serum (Gibco), 50 ml serum 
plus medium supplement (Sigma), 14 µl β-mercaptoethanol (Sigma), 8 ml of 200 mM 
glutamine (Sigma) and 10 ml penicillin/streptomycin solution (Sigma); storage at 4 ºC 
after filter-sterilization.  
2.3. Drug susceptibility assays 
Drug susceptibilities were determined for bloodstream-form T. b. brucei, B48 and 
ISMR1 using the Alamar blue (resazurin) assay as described previously, using 23 
doubling dilutions from an initial test compound concentration of 20 µM, and 105 
trypanosomes/well; plates were incubated at 37 ºC/5% CO2 for 48 h and 24 h before 
and afterthe addition of Alamar blue, respectively (Rodenko et al., 2007; Gould et al., 
2008).  EC50 values were calculated by non-linear regression using an equation for a 
sigmoidal dose–response curve with variable slope (Prism 5.0; GraphPad Software Inc). 
For Trypanosoma congolense, the same Alamar blue assay was used, but at a final cell 
density of 2.5×105 cells/ml (2.5×104 cells/well). 
 
3. Results and Discussion 
It is widely acknowledged that there is an urgent need for new drugs against animal 
trypanosomiasis; above anything else, this need is driven by the increasing failure of the 
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long-standing, cheap and widely available drugs isometamidium (ISM, Samorin® 
/Trypamidium®, Mérial; Veridium®, Sanofi), diminazene aceturate (Berenil®, Hoechst; 
Veriben®, Sanofi) and homidium bromide (Ethidium®, Laprovet) or homidium chloride 
(Novidium®, Mérial). AAT drug resistance has now been documented in at least 21 
African countries (Assefa and Shibeshi, 2018), a rapid increase from the reported 17 
countries in 2013 (Melaku and Birasa, 2013), and the emerging reality is that animal 
trypanosomiasis can no longer be effectively treated in many parts of Africa, with dire 
consequences for livelihoods, economies and food security (Giordani et al., 2016; 
Assefa and Shibeshi, 2018). As new drugs are at the very least years away from making 
a meaningful contribution in the field, it is essential that we make the most efficient use 
of the few licenced drugs available. Here we ask the question whether the purification 
of (any of) the Samorin components would result in a significantly more potent drug 
able to overcome current levels of resistance.  
The activity of compounds 1-4 against T. b. brucei s427, B48, ISMR1 and T. 
congolense are presented in Table 1 and Figure 2. The main observation was that 
Samorin was found to be consistently and significantly (P < 0.0001) more active than 
any of the fractions. Compound 2 was found to be consistently the most active of all the 
Samorin components, followed by the pure compound 1A, while compound 4 was 
consistently the least active. Samorin was 10.4-fold, 9-fold, 54-fold and 3.2-fold more 
active than compound 2 against T. congolense, Tb427, B48 and ISMR1, respectively. 
As expected, neither Samorin nor any of the fractions displayed cross-resistance with 
pentamidine in the B48 strain. Indeed, B48, a multi-drug resistant strain for all 
diamidines and melaminophenyl arsenicals, was 14.6-fold more sensitive to Samorin 
(P=0.00001) than the wild-type s427 cells. In addition, compounds 1, 2, and 3 all were 
significantly more active against this cell line, which was 124-fold resistant to 
pentamidine in this series of experiments (P<0.00001). Interestingly, ethidium bromide 
was less active against B48 (P<0.01), albeit by only 1.3-fold, which seems to indicate 
that at least some aspect of its mechanism of action or cellular entry is different from 
isometamidium. All the phenanthridines except 4 displayed significantly reduced 
activity for the isometamidium-resistant strain ISMR1. Indeed, the resistance factors of 
all the Samorin fractions and ethidium were highly similar (1.3 - 1.9-fold; Table 1), 
although the resistance to Samorin exceeded 5-fold with the present assay protocol.  
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Figure 2. Bar graphs showing the EC50 values obtained for Trypanosoma congolense 
IL3000, and wildtype s427, diamidine-resistant (B48) and ISM-resistant (ISMR1) T. b. 
brucei strains. EC50 values were determined from alamar blue assays using 105 cells/ml 
of each cell line. Each bar represents the average of at least three independent assays as 
indicated in Table 1; error bars are SEM. Statistical significance relative to wild-type T. 
b. brucei is also included in Table 1.  
 
The overall conclusion is that the impure Samorin is significantly more efficacious than 
each individual fraction in its pure form, suggesting a form of synergistic action by 
more than any one individual component. Moreover, all of the active compounds 
displayed reduced activity against the ISM resistant strain ISMR1, showing clearly that 
the production of any one of the pure compounds out of the Samorin mix is not a viable 
answer to the drug resistance crisis. Given these observations, and the fact that a pure 
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isometamidium would be much more expensive, we would advocate an increased 
investment in new AAT drug discovery instead.  
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Table 1. Overview of Samorin fractions and control drugs against T. congolense and T. b. brucei. 
 T. congolense 
IL3000 
T. brucei 
s427 
T. b. brucei 
B48 
T. b. brucei 
ISMR1 
compound EC50 (µM) n EC50 (µM) n EC50 (µM) n RF (s427) P value 
(s427) 
EC50 (µM) n RF 
(s427) 
P value 
(s427) 
1A 0.035 ± 0.005 5 3.48 ± 0.42 4 1.85 ± 0.19 4 0.53 0.012 5.64 ± 0.40 4 1.62 0.0093 
1B 0.65 ± 0.06 5 5.31 ± 0.48 4 5.58 ± 0.07 4 1.05 0.59 7.14 ± 0.14 4 1.34 0.010 
2 0.035 ± 0.005 5 2.67 ± 0.48 4 1.06 ± 0.11 4 0.40 0.017 4.97 ± 0.22 4 1.86 0.0047 
3 0.36 ± 0.02 5 12.2 ± 1.4 6 7.13 ± 0.43 6 0.59 0.005 17.4 ± 1.4 6 1.43 0.025 
4 16.0 ± 0.7 6 95.7 ± 17.0 4 86.1 ± 3.3 4 0.90 0.60 96.4 ± 24.6 4 1.01 0.98 
Samorin 0.0033 ± 0.0006 17 0.29 ± 0.04 12 0.020 ± 0.005 10 0.068 0.00001 1.55 ± 0.05 14 5.33 >0.00001 
Ethidium 0.11 ± 0.01 5 3.85 ± 0.22 4 5.03 ± 0.17 4 1.31 0.0051 7.41 0.23 4 1.92 0.00003 
Pentamidine 0.82 ± 0.02 11 0.0051 ± 0.0004 6 0.63 ± 0.03 6 124 >0.00001 0.016 ± 0.002 6 3.24 >0.00001 
The 50% Effective Concentration (EC50) is given as average and SEM, and the number of replicates (n) for each determination is included in a 
separate column. RF is the Resistance Factor, the ratio of EC50 (s427) and EC50 (B48 or ISMR1). The P value is the outcome of an unpaired, 
two-tailed Student’s t-test of the B48 or ISMR1 EC50 with the corresponding value of s427. 
 
